UA cancer center building

Dr. William Cance“We only have one competitor — cancer. The two-day event is designed to promote thoughtful discussion and a strategic plan of action to enhance collaboration and discovery.”
— William Cance, MD
Deputy Director, University of Arizona Cancer Center Phoenix

The Symposium was a dedicated platform for cancer researchers from diverse groups across the region to gather knowledge and promote collaboration. The enriching agenda included:

Event Details

Keynote Speakers

Speaker Presentation and Brief Bio
Edison T. Liu, MD
Edison T. Liu, MD

President and CEO, The Jackson Laboratory

Presentation – “Integrated Sciences for Clinical Translation: Genomics of Triple Negative Breast Cancer”

Dr. Liu is the president and CEO of The Jackson Laboratory, an independent, not-for-profit organization focusing on mammalian genetics and functional genomics research to advance human health. At the Laboratory, he has overseen initiatives including the opening of a new genomics research campus in Connecticut, the development and growth of strong research programs in new areas including immunology and the microbiome, the renewal of NCI-designation for JAX’s Cancer Center, the launch of a collaborative Maine Cancer Genomics Initiative to expand access to genomic medicine and the expansion of philanthropic support for the Laboratory, including the two largest gifts in JAX’s history...

Louis M. Lerner, MD
Louis M. Weiner, MD

Director of the Lombardi Comprehensive Cancer Center at Georgetown University

Presentation – “Overcoming Resistance to Immunotherapy and Progress in Cancer Resistance”

Dr. Louis Weiner is director of Georgetown Lombardi Comprehensive Cancer Center. He holds the Francis L. and Charlotte G. Gragnani Chair and is professor of oncology at Georgetown University Medical Center.

He is responsible for the operation and development of the cancer center, including its research, clinical and educational missions. The clinical mission includes leading the MedStar-Georgetown Cancer Network in the metropolitan Washington area. Weiner is known for his laboratory and clinical research focusing on new therapeutic approaches that mobilize the patient’s immune system to fight cancer using monoclonal antibodies and other modalities of therapy...


Friday, October 6, 2017
2:00 – 2:55 p.m.

Registration, networking and hanging posters in the lobby outside Conference Room 113/115

2:55 – 3:15 p.m.

Welcome and Opening Remarks – UACC Director Andrew Kraft, MD, Phoenix Mayor Greg Stanton and Dean Guy Reed, MD, MS

3:15 – 4:15 p.m.

Scientific Session – Moderated by William Cance, MD

Opening Remarks, Overview of Symposium, Opportunities for Collaboration in Drug Discovery – William Cance, MD

The UACC – One Cancer Center, Two Sites: Statewide Impact – Andrew Kraft, MD

Integrating Genetics, Genomics and Biology toward a More Personalized Medicine – Jeff Trent, PhD

A Phase 0 Clinical Trials Program for Brain Tumors – Nader Sanai, MD

4:15 – 5:15 p.m.

Introduction and Keynote Speaker
Overcoming Resistance to Immunotherapy and Progress in Cancer Resistance –
 Louis Weiner, MD

5:15 – 6:30 p.m. Happy hour and networking Drinks and hors d’oeuvres served in the Grand Canyon Patio
Saturday, October 7, 2017
7:00 – 7:55 a.m.

Buffet breakfast served in the Grand Canyon Patio

7:55 – 8:00 a.m.

Opening Remarks – Leigh Neumayer MD, MS, UA Interim Senior Vice President for Health Sciences

8:00 – 9:15 a.m.

Scientific Session – Moderated by Andrew Kraft, MD

Oncolytic Virotherapy and Immunotherapy in Arizona – Grant McFadden, PhD

Synergies for Cancer Immunity – Protul Shrikant, PhD

Precision Cancer Prevention: Obstacles and The Way Forward – Peter Lance, MD

Mayo Clinic Cancer Center: Overview of Arizona Programs – Richard Gray, MD

Putting Cancer in Focus: Biomedical Imaging Progress and Opportunities – Jennifer Barton, PhD

9:15 – 10:15 a.m.

Poster session and refreshment break

10:15 – 11:45 a.m.

Scientific Session – Moderated by Michael Berens, PhD

Current Research and Future Opportunities in Lung and Esophageal Cancer Research at Norton Thoracic Institute – Ross Bremner MD, PhD

Emerging Paradigm Shift in Lung Cancer Through Early Detection and Analysis of Pre-cancer for Chemoprevention – Alan Nelson PhD

An Aspirin a Day...Precision Medicine in PIK3CA-Altered Head and Neck Cancer – Julie Bauman, MD, MPH

Integrating Genomics and Patient-Derived Models to Advance Precision Therapy: Opportunities in AZ-Wide Collaborations – Erik Knudsen, PhD

Collaborative Drug Discovery: Development of Reversible Lysine Specific Demethylase-1 (LSD-1) Inhibitors for Treatment of Cancer – Sunil Sharma, MD

11:45 a.m. – 1:00 p.m.

Buffet lunch and roundtable discussions:

  • Cancer Imaging – Moderated by Jennifer Barton, PhD
  • Cancer Prevention and Control – Moderated by Peter Lance, MD
  • Cancer Biology – Moderated by Nathan Ellis, PhD
  • Drug Discovery/Therapeutic Development – Moderated by Rick Schnellmann, PhD
  • All-Arizona Clinical Trials – Moderated by Daniel Persky, MD and Panos Savvides, MD, PhD, MPH
1:00 – 2:00 p.m. Introduction and Keynote Speaker
Integrated Sciences for Clinical Translation: Genomics of Triple Negative Breast Cancer – Edison Liu, MD
2:00 – 2:30 p.m. Town hall, open forum; discussion of next steps with moderator William Cance, MD
2:30 p.m. Symposium concluded

Thanks to our generous sponsors, the Flinn FoundationDignity Health at St. Joseph’s Hospital and Medical Center and the University of Arizona Cancer Center Support Grant, there was no cost to attend the Symposium.